1. Home
  2. PCVX vs ENS Comparison

PCVX vs ENS Comparison

Compare PCVX & ENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • ENS
  • Stock Information
  • Founded
  • PCVX 2013
  • ENS 1991
  • Country
  • PCVX United States
  • ENS United States
  • Employees
  • PCVX N/A
  • ENS N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • ENS Industrial Machinery/Components
  • Sector
  • PCVX Health Care
  • ENS Technology
  • Exchange
  • PCVX Nasdaq
  • ENS Nasdaq
  • Market Cap
  • PCVX 4.0B
  • ENS 3.4B
  • IPO Year
  • PCVX 2020
  • ENS N/A
  • Fundamental
  • Price
  • PCVX $40.80
  • ENS $126.01
  • Analyst Decision
  • PCVX Strong Buy
  • ENS Strong Buy
  • Analyst Count
  • PCVX 8
  • ENS 2
  • Target Price
  • PCVX $114.17
  • ENS $117.50
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • ENS 374.5K
  • Earning Date
  • PCVX 11-05-2025
  • ENS 11-05-2025
  • Dividend Yield
  • PCVX N/A
  • ENS 0.85%
  • EPS Growth
  • PCVX N/A
  • ENS 32.64
  • EPS
  • PCVX N/A
  • ENS 8.77
  • Revenue
  • PCVX N/A
  • ENS $3,657,687,000.00
  • Revenue This Year
  • PCVX N/A
  • ENS $2.83
  • Revenue Next Year
  • PCVX N/A
  • ENS $3.01
  • P/E Ratio
  • PCVX N/A
  • ENS $14.04
  • Revenue Growth
  • PCVX N/A
  • ENS 3.73
  • 52 Week Low
  • PCVX $27.66
  • ENS $76.57
  • 52 Week High
  • PCVX $116.00
  • ENS $127.66
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 47.89
  • ENS 63.42
  • Support Level
  • PCVX $43.12
  • ENS $122.02
  • Resistance Level
  • PCVX $45.90
  • ENS $127.66
  • Average True Range (ATR)
  • PCVX 1.86
  • ENS 3.00
  • MACD
  • PCVX -0.59
  • ENS -0.14
  • Stochastic Oscillator
  • PCVX 15.01
  • ENS 84.64

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

Share on Social Networks: